Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin + Irinotecan in Refractory Colorectal Cancer
NCT01930864Phase 2Unknown
- Sponsor
- Hospital de Amor
- Start
- Sep 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in colorectal cancer (CRC), sponsored by Hospital de Amor. Primary endpoint: Non-Progression at 12 weeks. Status: unknown.
02
Drugs
metformin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01930864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01930864.